To investigate the effects of valproic acid (VPA) on renal tubular function
, we examined 15 ambulatory children with epilepsy who received VPA for at
least 6 months. None of the patients had mental retardation. Fourteen age-
and sex-matched children were used as a control group. No statistically sig
nificant differences were. found between patients and control subjects with
respect to blood urea nitrogen (BUN), creatinine (Cr), uric acid, creatini
ne clearance (C-Cr), tubular reabsorption of phosphorus (TRP), urinary Ca:c
reatinine ratio, urinary pH and mean urinary beta (2)-microglobulin concent
rations (P>0.05). Protein and glucose in patient urine samples were negativ
e. Urine microscopic examinations and amino acid chromatographies of patien
ts were also normal. However, significant differences were found between pa
tient and control groups with respect to mean urinary N-acetyl-beta-D-gluco
samine:creatinine ratio (NAG:Cr) and mean urinary malondialdehyde:creatinin
e (MDA:Cr) ratio (P<0.05). In conclusion, ambulatory children with epilepsy
taking VPA therapy may develop proximal renal tubular dysfunction. Althoug
h this finding is clinically insignificant, it should be kept in mind durin
g VPA therapy.